Loading stock data…
COCP
$1.38-0.05 (-3.50%)
Market ClosedLast close May 1
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cocrystal Pharma, Inc. in the Healthcare sector is trading at $1.38. The stock is currently 48% below its 52-week high of $2.67, remaining 13.1% above its 200-day moving average. Technical signals show neutral RSI of 46 and bearish MACD signal, explaining why COCP maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 46) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.38
Potential Upside
5%
Whystock Fair Value$1.45
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$20.27M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.18
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-139.49%
Volume
Today's trading volume
144,386
Recent News
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da